NCT02331537

Brief Summary

The purpose of this study is to examine if an internet-based exposure therapy is effective in reducing excessive worry amongst patients who suffer from this problem.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
140

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 1, 2015

Completed
Same day until next milestone

Study Start

First participant enrolled

January 1, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 6, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2015

Completed
Last Updated

September 1, 2015

Status Verified

August 1, 2015

Enrollment Period

5 months

First QC Date

January 1, 2015

Last Update Submit

August 31, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Penn State Worry Questionnaire (PSWQ)

    Change in worry from baseline to Week 10, and at 4- and 12 months after treatment has ended.

    Week 0, Week 10, Long term follow-up at 4-, and 12-months after treatment has ended

Secondary Outcomes (8)

  • Meta Cognitions Questionnaire (MCQ-30)

    Week 0, Week 10, long term follow-up at 4- and 12- months after treatment has ended

  • Montgomery Åsberg Depression Rating Scale - Self-report (MADRS-S)

    Week 0, Week 10, long term follow-up at 4- and 12- months after treatment has ended

  • Euroqol (EQ-5D)

    Week 0, Week 10, long term follow-up at 4- and 12- months after treatment has ended

  • Hospital anxiety and depression scale (HADS)

    Week 0, Week 10, long term follow-up at 4- and 12- months after treatment has ended

  • Spontaneous Use of Imagery Scale (SUIS)

    Week 0, Week 10, long term follow-up at 4- and 12- months after treatment has ended

  • +3 more secondary outcomes

Study Arms (2)

Internet-based cognitive-behavior therapy

EXPERIMENTAL

The experimental group will go through active internet-based treatment. The treatment is 10 weeks long and is based on the principles of exposure i.e. the participant is instructed to stay with the frightening thought until it is no longer associated with anxiety.

Behavioral: Internet-based cognitive-behavior therapy

Waitlist

NO INTERVENTION

Waitlist control that will get the internet-based treatment when the first group has finished (i.e. Week 10). There are no active treatment for these participants at all.

Interventions

Internet-based cognitive-behavior therapy on a safe internet platform. Treatment is divided into seven modules, each containing homework assignments . The participants will be assigned a therapist that they can contact through a message system in the platform and expect answer within 24 hours.

Internet-based cognitive-behavior therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Outpatients
  • ≥ 18 years
  • Situated in Sweden
  • Informed consent
  • Penn State Worry Questionnaire score more than 56 points

You may not qualify if:

  • Substance dependence during the last six months
  • Post traumatic stress disorder, bipolar disorder or psychosis
  • Symptoms better explained by axis 2 diagnosis (e.g. autism or borderline personality disorder)
  • MADRS-S score above 25 points
  • Psychotropic medication changes within two months prior to treatment that could affect target symptoms.
  • Received exposure based Cognitive behavior therapy (CBT) for pathological worry the last 2 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet

Stockholm, Stockholm County, 17177, Sweden

Location

MeSH Terms

Conditions

Rumination Syndrome

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesFeeding and Eating DisordersMental Disorders

Study Officials

  • Erik M Andersson, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD, psychologist

Study Record Dates

First Submitted

January 1, 2015

First Posted

January 6, 2015

Study Start

January 1, 2015

Primary Completion

June 1, 2015

Study Completion

June 1, 2015

Last Updated

September 1, 2015

Record last verified: 2015-08

Locations